---
figid: PMC7053123__12943_2020_1169_Fig4_HTML
figlink: pmc/articles/PMC7053123/figure/Fig4/
number: F4
caption: Gemcitabine resistance and metabolism. Gemcitabine and some intrinsic characteristics
  of pancreatic cancer cells produce chemoresistance. Ovals are biological substances,
  rectangles are processes, and hexagons are statuses. Red names indicate corresponding
  inhibitors. Arrows represent positive regulations, and lines with blunt ends represent
  negative regulations. CR, chemoresistance; EMT, epithelial-mesenchymal transition;
  FBP1, fructose-1,6-bisphosphatase 1; IDH1, isocitrate dehydrogenase 1; LAT2, L-type
  amino acid transporter 2; noPPP, nonoxidative pentose phosphate pathway; RRM2, ribonucleotide
  reductase subunit-M2
pmcid: PMC7053123
papertitle: 'Metabolism of pancreatic cancer: paving the way to better anticancer
  strategies.'
reftext: Cheng Qin, et al. Mol Cancer. 2020;19:50.
pmc_ranked_result_index: '48359'
pathway_score: 0.7962794
filename: 12943_2020_1169_Fig4_HTML.jpg
figtitle: Gemcitabine resistance and metabolism
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7053123__12943_2020_1169_Fig4_HTML.html
  '@type': Dataset
  description: Gemcitabine resistance and metabolism. Gemcitabine and some intrinsic
    characteristics of pancreatic cancer cells produce chemoresistance. Ovals are
    biological substances, rectangles are processes, and hexagons are statuses. Red
    names indicate corresponding inhibitors. Arrows represent positive regulations,
    and lines with blunt ends represent negative regulations. CR, chemoresistance;
    EMT, epithelial-mesenchymal transition; FBP1, fructose-1,6-bisphosphatase 1; IDH1,
    isocitrate dehydrogenase 1; LAT2, L-type amino acid transporter 2; noPPP, nonoxidative
    pentose phosphate pathway; RRM2, ribonucleotide reductase subunit-M2
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LAT2
  - FASN
  - MTOR
  - PKM
  - USP9X
  - IDH1
  - NAMPT
  - MUC1
  - MAPK3
  - MAPK1
  - ELAVL1
  - FBP1
  - HIF1A
  - E2F1
  - STAT3
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - RBMS1
  - RRM2
  - TP53
  - Chloroquine
  - Orlistat
  - NADPH
  - Gemcitabine
  - NAD
  - FK866
  - Gambolic Acid
  - Pyrimidine
  - leflunomide
  - Digoxin
  - w3 fatty acids
  - Hypoxia
genes:
- word: LAT2
  symbol: LAT2
  source: hgnc_symbol
  hgnc_symbol: LAT2
  entrez: '7462'
- word: FASN
  symbol: FASN
  source: hgnc_symbol
  hgnc_symbol: FASN
  entrez: '2194'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PKM2
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: USP9X
  symbol: USP9X
  source: hgnc_symbol
  hgnc_symbol: USP9X
  entrez: '8239'
- word: LAT2
  symbol: LAT2
  source: hgnc_symbol
  hgnc_symbol: LAT2
  entrez: '7462'
- word: IDH1
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: Nampt
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: MUC1
  symbol: MUC1
  source: hgnc_symbol
  hgnc_symbol: MUC1
  entrez: '4582'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HuR
  symbol: HuR
  source: hgnc_alias_symbol
  hgnc_symbol: ELAVL1
  entrez: '1994'
- word: FBP1)
  symbol: FBP1
  source: hgnc_symbol
  hgnc_symbol: FBP1
  entrez: '2203'
- word: (GambolicAcid,FBP1)
  symbol: FBP1
  source: hgnc_symbol
  hgnc_symbol: FBP1
  entrez: '2203'
- word: HIF-1a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: E2F1
  symbol: E2F1
  source: hgnc_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: NF-KB/STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: NF-KB/STAT3
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB/STAT3
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB/STAT3
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB/STAT3
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB/STAT3
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: YC1)
  symbol: YC1
  source: hgnc_alias_symbol
  hgnc_symbol: RBMS1
  entrez: '5937'
- word: (Digoxin,YC1)
  symbol: YC1
  source: hgnc_alias_symbol
  hgnc_symbol: RBMS1
  entrez: '5937'
- word: RRM2
  symbol: RRM2
  source: hgnc_symbol
  hgnc_symbol: RRM2
  entrez: '6241'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
chemicals:
- word: Chloroquine
  source: MESH
  identifier: D002738
- word: Orlistat
  source: MESH
  identifier: C055122
- word: NADPH
  source: MESH
  identifier: D009249
- word: Gemcitabine
  source: MESH
  identifier: C056507
- word: NAD
  source: MESH
  identifier: D009243
- word: FK866
  source: MESH
  identifier: C480543
- word: Gambolic Acid
  source: MESH
  identifier: D000596
- word: Pyrimidine
  source: MESH
  identifier: C030986
- word: leflunomide
  source: MESH
  identifier: C045463
- word: Digoxin
  source: MESH
  identifier: D004077
- word: w3 fatty acids
  source: MESH
  identifier: C094464
diseases:
- word: Hypoxia
  source: MESH
  identifier: D000860
figid_alias: PMC7053123__F4
redirect_from: /figures/PMC7053123__F4
figtype: Figure
---
